类风湿关节炎慢性化的发生时机与机制:迈向时间与组织整合视角
本文为叙述性综述,整合时间与组织维度探讨类风湿关节炎在临床关节炎出现前的慢性化发展轨迹,涵盖自身免疫出现与成熟、系统性炎症改变、亚临床及临床关节炎症阶段,并讨论不同轨迹的可逆性差异及多打击假说、组学研究和预防试验对可干预检查点的启示。
要点
- 临床关节炎出现不等于生物学发病,慢性化在 preclinical 阶段已历经数年发展。
- ACPA 阳性与阴性类风湿关节炎的慢性化轨迹需分别考量。
- 部分免疫扰动可缓解,部分进展为自我维持性疾病,可逆性因轨迹而异。
核心结论
- 类风湿关节炎慢性化在临床关节炎出现前的 preclinical 阶段即已沿时间与组织维度逐步发展。
- 不同疾病轨迹的可逆性可能存在差异,部分免疫扰动可缓解而部分进展为自我维持性疾病。
研究设计与样本
- 叙述性综述,整合时间与组织视角审视类风湿关节炎慢性化发展轨迹。
主要发现
- 早期阶段以自身免疫的出现与成熟及系统性炎症改变为特征。
- 随后进入亚临床关节炎症阶段,继而出现临床关节炎症。
- 上述阶段在 ACPA 阳性与 ACPA 阴性类风湿关节炎中均有讨论。
- 多打击假说、近期组学研究及预防试验结果有助于识别进展为慢性病仍可干预的检查点。
临床怎么用
- 认识临床关节炎前的慢性化轨迹有助于在可干预检查点识别进展风险。
- 应区分 ACPA 阳性与阴性类风湿关节炎的不同轨迹评估可逆性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the diagnosis of rheumatoid arthritis can usually be made once clinical arthritis appears, this moment does not represent the biological onset of disease. Rheumatoid arthritis develops over a period of years in preclinical phases that precede the emergence of persistent joint inflammation. In this narrative Review, we examine how chronicity develops along this trajectory by integrating temporal and tissue perspectives. We discuss early disease phases characterised by the emergence and maturation of autoimmunity and systemic inflammatory shifts, followed by stages marked by subclinical and subsequently clinical joint inflammation, in both anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis. We consider how some immune perturbations could resolve in some individuals, while others progress to self-sustaining disease, highlighting that reversibility might differ across disease trajectories. Lastly, we examine how evolving multi-hit hypotheses, recent omics studies, and results from prevention trials inform the identification of checkpoints at which progression to chronic disease might still be modifiable.
引用
- Cevirgel A, van der Helm-van Mil AHM. When and how chronicity develops in rheumatoid arthritis: towards a temporal and tissue-integrated perspective. Lancet Rheumatol. 2026. PMID: 42447886. doi:10.1016/S2665-9913(26)00107-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。